Kazia Therapeutics Ltd's promising data on treatment targeting brain metastases to be presented at conference
Kazia Therapeutics Ltd (ASX:KZA, NASDAQ:KZIA)'s ongoing Phase 1 clinical trial tackling brain metastases, using paxalisib in combination with radiotherapy,...